Tradestie Institutional Equity Comparison Engine

GRAL vs SHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SHC Overall Edge

SHC Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sotera Health Company Common Stock (SHC) driven by superior Growth & Margin, Options & Structure while GRAL counters with relative strength in Valuation, Momentum & Technical. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus SHC at 15.3x Forward P/E and 36.8% operating margin (+4.4% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against SHC sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs SHC 15.3x Fwd P/E
Growth & Margin Winner SHC
Op Margin -332.0% vs 36.8% ยท YoY +3.7% vs +4.4%
Momentum & Technical Winner GRAL
1Y +24.6% vs +1.5% ยท 52W Pos 51% vs 47%
Options & Structure Winner SHC
BREAKDOWN (53rd %ile IV) vs UNCLASSIFIED (6th %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
SHC NASDAQ
Sotera Health Company Common Stock
Services-Misc Health & Allied Services, Nec
$16.25
-2.17% 1D
Market Cap $4.7B
1M Return -9.17%
1Y Return +1.5%
Forward P/E 15.3x
Unified AI Score
63.1 / 100 BUY
Tech 60.0 Fund 56.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% SHC +1.5% Spread: +25.42 pp (GRAL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GRAL TTM Op. Margin: -332.0% SHC TTM Op. Margin: 36.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRAL vs SHC. Trailing 12-month operating profitability (GRAL -332.0% vs SHC 36.8%) and valuation multiples (GRAL 1.1x vs SHC 15.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (4) vs SHC (6)
Institutional Metric GRAL SHC Criterion Row Winner
Market Capitalization Scale $5.2B $4.7B Larger Scale GRAL
Trailing P/E Ratio Valuation 1.1x 27.7x Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x 15.3x Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% +4.4% Higher Growth SHC
Operating Margin (TTM) Profitability -332.0% 36.8% Higher Margin SHC
Net Profit Margin Profitability -243.8% 14.1% Higher Margin SHC
Return on Equity (ROE) Capital Efficiency -17.3% 27.0% Higher ROE SHC
52-Week Range Position Momentum 51% ($42โ€“$166) 47% ($13โ€“$20) Stronger Trend GRAL
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol 0.95ฮฒ ยท 44% Vol Lower Realized Risk SHC
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 63.1 / 100 (BUY) Higher Composite SHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs SHC Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SHC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live SHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor SHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.